| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0008 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |